Most interestingly is the fact that when looking at the gynecological cancers, EP3 expression either proves a positive effect on survival rates e.g., on BC [15] or a negative one, e.g., on ovarian [16] and cervical cancer [17]. Here, PTGER3 is linked to female reproductive organ cancer.